Clozapine-Induced Febrile Neutropenia and Cellulitis

Clozapine is one of the atypical antipsychotics and is frequently prescribed to patients with treatment-resistant schizophrenia. Agranulocytosis is a major side effect that may lead to death, which limits its use. This is a case report of a patient that developed febrile neutropenia and cellulitis a...

Descripción completa

Detalles Bibliográficos
Autores principales: YAYLACI, Selcuk, YILMAZ, Emine Ulku, GUCLU, Ertugrul, KUMSAR, Neslihan AKKISI, TAMER, Ali, KARABAY, Oguz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909868/
https://www.ncbi.nlm.nih.gov/pubmed/27331165
http://dx.doi.org/10.5505/1304.7361.2014.83097
_version_ 1782437900010389504
author YAYLACI, Selcuk
YILMAZ, Emine Ulku
GUCLU, Ertugrul
KUMSAR, Neslihan AKKISI
TAMER, Ali
KARABAY, Oguz
author_facet YAYLACI, Selcuk
YILMAZ, Emine Ulku
GUCLU, Ertugrul
KUMSAR, Neslihan AKKISI
TAMER, Ali
KARABAY, Oguz
author_sort YAYLACI, Selcuk
collection PubMed
description Clozapine is one of the atypical antipsychotics and is frequently prescribed to patients with treatment-resistant schizophrenia. Agranulocytosis is a major side effect that may lead to death, which limits its use. This is a case report of a patient that developed febrile neutropenia and cellulitis after treatment with clozapine for 20 weeks.
format Online
Article
Text
id pubmed-4909868
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-49098682016-06-21 Clozapine-Induced Febrile Neutropenia and Cellulitis YAYLACI, Selcuk YILMAZ, Emine Ulku GUCLU, Ertugrul KUMSAR, Neslihan AKKISI TAMER, Ali KARABAY, Oguz Turk J Emerg Med Case Report Clozapine is one of the atypical antipsychotics and is frequently prescribed to patients with treatment-resistant schizophrenia. Agranulocytosis is a major side effect that may lead to death, which limits its use. This is a case report of a patient that developed febrile neutropenia and cellulitis after treatment with clozapine for 20 weeks. Elsevier 2016-02-26 /pmc/articles/PMC4909868/ /pubmed/27331165 http://dx.doi.org/10.5505/1304.7361.2014.83097 Text en © 2014 Emergency Medicine Association of Turkey. Production and Hosting by Elsevier B.V. Originally published in [2014] by Kare Publishing. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
YAYLACI, Selcuk
YILMAZ, Emine Ulku
GUCLU, Ertugrul
KUMSAR, Neslihan AKKISI
TAMER, Ali
KARABAY, Oguz
Clozapine-Induced Febrile Neutropenia and Cellulitis
title Clozapine-Induced Febrile Neutropenia and Cellulitis
title_full Clozapine-Induced Febrile Neutropenia and Cellulitis
title_fullStr Clozapine-Induced Febrile Neutropenia and Cellulitis
title_full_unstemmed Clozapine-Induced Febrile Neutropenia and Cellulitis
title_short Clozapine-Induced Febrile Neutropenia and Cellulitis
title_sort clozapine-induced febrile neutropenia and cellulitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909868/
https://www.ncbi.nlm.nih.gov/pubmed/27331165
http://dx.doi.org/10.5505/1304.7361.2014.83097
work_keys_str_mv AT yaylaciselcuk clozapineinducedfebrileneutropeniaandcellulitis
AT yilmazemineulku clozapineinducedfebrileneutropeniaandcellulitis
AT gucluertugrul clozapineinducedfebrileneutropeniaandcellulitis
AT kumsarneslihanakkisi clozapineinducedfebrileneutropeniaandcellulitis
AT tamerali clozapineinducedfebrileneutropeniaandcellulitis
AT karabayoguz clozapineinducedfebrileneutropeniaandcellulitis

Ejemplares similares